NARA Discovery
Article Details
← Back to Search Results
Journal Article

The dual endothelin A and angiotensin II type 1 receptor antagonist sparsentan (FILSPARI®) exhibits a safe nonclinical male fertility toxicity profile

Patricia W. Bedard; Francesca Pretto; Sima Patel; Celia Jenkinson; Tacey White; Donald E. Kohan
Regulatory Toxicology and Pharmacology · Vol. 156 · pp. 105770 · 2025
View Full Text Download RIS Journal Homepage

Abstract

Abstract is unavailable.

Bibliographic Information

JournalRegulatory Toxicology and Pharmacology
PublisherAcademic Press
Publication Date2025-02-01
Publication Year2025
Volume156
Pages105770
Document TypeJournal Article
eISSN0273-2300
DOI10.1016/j.yrtph.2024.105770
SubjectEnvironmental Science

Access Information

NARA Access Coverage1981-06-01~Current
Journal Homepagehttps://www.sciencedirect.com/science/journal/02732300
Publisher PageOpen Publisher Page
Full-text access depends on NARA's subscribed coverage and institutional access.